Alexander Rabinovich

InterCure Stock Trading Lower On Q1 Revenue Growth Of 22%, Here Are The Details

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) released its financial results for the first quarter ended March 31, 2023, revealing revenue of NIS 106 million ($29 million) representing 22% growth YoY and up 1% sequenti

InterCure Shares Soar On FY22 Record Revenue Of $108.3M

InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) fiscal year 2022 revenue was NIS 388.7 million ($108.3 million), an increase of 77% compared to NIS 219.7 million in 2021.